Motor cortex

Mitsubishi Electric Corporation Leads Series B Investment in Realtime Robotics

Retrieved on: 
星期二, 五月 28, 2024
Technology, Other Science, Food, Beverage, Retail, Automotive, Semiconductor, Other Transport, Science, Transport, Other Manufacturing, Other Technology, Software, General Automotive, Supply Chain Management, Packaging, Online Retail, Engineering, Hardware, Automotive Manufacturing, Electronic Design Automation, Other Retail, Logistics, Manufacturing, 3D, Schaeffler Group, Mitsubishi Electric, Automation, FA, Motor cortex, Volkswagen Commercial Vehicles, Artificial intelligence, AmeriCorps, Face, BMW, Robotics, Meal

Realtime Robotics , the leader in collision-free autonomous motion planning for industrial robots, today announced that it has secured a strategic investment from Mitsubishi Electric Corporation .

Key Points: 
  • Realtime Robotics , the leader in collision-free autonomous motion planning for industrial robots, today announced that it has secured a strategic investment from Mitsubishi Electric Corporation .
  • This is the lead investment in Realtime Robotics’ recently opened Series B round.
  • Mitsubishi Electric was also a participant in the Series A round , and will be adding a senior representative to Realtime’s Board of Directors.
  • Realtime Robotics’ unique and innovative collision-free path planning technology provides solutions across the lifecycle of robotic workcells.

MeiraGTx Reports First Quarter 2024 Financial and Operational Results

Retrieved on: 
星期四, 五月 9, 2024
FDA, Research, UCL Business, Weight loss, IND, Oxyntomodulin, Visual acuity, RIX, Oral medicine, American Academy, Brain, STN, Facial muscles, Technology transfer, Janssen Pharmaceuticals, Appetite, BLA, MHRA, Messenger, Subthalamic nucleus, Safety, Diabetes, Insurance, RNA, AAOM, AAV, Dopamine, Obesity, DNA, Autoimmune disease, Motor cortex, Treatment, Pros, GMP, GIP, Clinical trial, File, PSMA, Sale, Radiation, Neurodegenerative disease, DSM-IV codes, Saliva, Health care, Xerostomia, Patient, Riboswitch, Gene, Peptide, Head, PYY, Pharmaceutical industry

LONDON and NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial and operational results for the first quarter ended March 31, 2024, and provided a corporate update.

Key Points: 
  • MeiraGTx anticipates receiving an additional $15 million in near-term milestone payments later in 2024.
  • As of March 31, 2024, MeiraGTx had cash and cash equivalents of approximately $119.2 million and in April 2024, the Company collected $19.7 million in receivables which were due in the first quarter of 2024, effectively increasing the cash balance to $138.9 million.
  • The increase of $0.6 million was due to higher interest rates and cash balances during 2024.
  • Interest expense was $3.3 million for the three months ended March 31, 2024, compared to $3.1 million for the three months ended March 31, 2023.

Rice Biotech Launch Pad startup Motif Neurotech announces peer-reviewed publication on wireless cortical stimulator for precise neuromodulation

Retrieved on: 
星期五, 四月 12, 2024
Leg, Brain, Inflammation, College of Engineering (KNUST), Post-traumatic stress disorder, Safety, Neuromodulation, Science Advances, Animal, Field line, Hand, Pathology, Depression, Tic disorder, Motor cortex, Mental health, Patient, Spinal cord, Miniature, DOT, DSM-IV codes, Transcranial magnetic stimulation, Digital, Manuscript, Rice University, TMS

HOUSTON, April 12, 2024 /PRNewswire/ -- Rice University today announced that Jacob Robinson, a professor of electrical and computer engineering and of bioengineering and founder and chief executive officer of Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health formed through the Rice Biotech Launch Pad, published a peer-reviewed study in Science Advances detailing a novel and wireless device - an epidural cortical stimulator known as the Digitally programmable Over-brain Therapeutic (DOT), that is capable of receiving enough energy to stimulate human and large-animal brain activity and can deliver bursts of electrical stimulation to the brain through the dura, the tough membrane that covers the brain and the spinal cord. The manuscript entitled "Miniature battery-free epidural cortical stimulators" can be viewed on the Science Advances website.

Key Points: 
  • The manuscript entitled " Miniature battery-free epidural cortical stimulators " can be viewed on the Science Advances website.
  • "However, current neuromodulation devices are either bulky, invasive, or limited in their stimulation capabilities.
  • It overcomes challenges by using a battery-free and wireless approach  to create an implant that can deliver precise and programmable stimulation to the brain, without brain surgery."
  • The study details how the DOT stimulator works by using magnetoelectric antennas that can convert magnetic fields into electric fields and vice versa.

Synchron Launches Patient Registry for Stentrode Brain Computer Interface

Retrieved on: 
星期一, 四月 8, 2024
Medical Devices, Health, Neurology, Health Technology, Other Health, Biotechnology, Brain, BCI, Motor cortex, Communication, Patient, UPMC, University, Disability studies, Movement, Physician, Pathology, Medical device

The Synchron BCI represents a novel approach to restoring functionality in patients with limited mobility.

Key Points: 
  • The Synchron BCI represents a novel approach to restoring functionality in patients with limited mobility.
  • By leveraging the natural highways of the brain, an individual’s blood vessels, the device is implanted in the brain without the need for invasive brain surgery.
  • “We are thrilled to launch our community-centered BCI registry,” said Tom Oxley, CEO & Founder, Synchron.
  • For more information about the Synchron BCI and our registry, visit https://synchronbci.com .

Precision Neuroscience Expands Clinical Research In Brain–Computer Interface

Retrieved on: 
星期五, 三月 22, 2024
Brain, BCI, Motor cortex, Assistant, Associate, Partnership, University, Patient, Deep brain stimulation, DSM-IV codes, Research, Sale, Electrode, Parkinson's disease, Trial of the century, Behavior, Hospital, Optimism, Precision, DBS, Mount Sinai Health System, Movement, Hand, Health, Medical device

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at Mount Sinai Health System and Perelman School of Medicine at the University of Pennsylvania (Penn Medicine).

Key Points: 
  • NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at Mount Sinai Health System and Perelman School of Medicine at the University of Pennsylvania (Penn Medicine).
  • Its design allows for safe implantation and removal by neurosurgeons without causing harm to delicate brain tissue.
  • Dr. Ben Rapoport, Chief Science Officer and co-founder of Precision Neuroscience, underscored the significance of these studies in advancing both medical science and patient care.
  • This partnership aims to explore the diverse applications of high-resolution cortical surface arrays in clinical settings, ranging from intraoperative monitoring to neurocritical care.

Brain Recordings in People Before Surgery Reveal How All Minds Plan What to Say Prior to Speaking

Retrieved on: 
星期二, 三月 19, 2024
Neurology, Epilepsy, Speech, Brain mapping, Brain, Motor cortex, Allegiant Air, NYU Langone Health, Seizure, Patient, Tongue, Research, NYU, Doctor of Philosophy, Publishing, Surgeon, Mouth, National Institutes of Health, Cerebral cortex, Bangladesh Technical Education Board, Vocal cords, Human, Medical imaging

Less clear until now was how closely these regions determine the mix of sounds and words people want to say aloud, the authors report.

Key Points: 
  • Less clear until now was how closely these regions determine the mix of sounds and words people want to say aloud, the authors report.
  • As a routine part of their procedures, surgeons electrically (and painlessly) stimulate specific parts of the brain while asking patients to perform standardized speaking tasks.
  • This enables surgeons to remove only the brain tissue responsible for the errant electrical signals that cause seizures.
  • Researchers say these shorter interruptions of speech indicate that these regions play a more crucial role in the physical mechanics of speaking.

Pison Launches New Class of Sports Performance Wearable with Sponsorship of NASCAR Driver Anthony Alfredo

Retrieved on: 
星期二, 二月 13, 2024
Consumer Electronics, Sports, Technology, Other Technology, Mobile, Wireless, General Sports, Artificial Intelligence, Sickness, Daytona, SRT, Multimedia, NASCAR, NASCAR Xfinity Series, Prefrontal cortex, Skin, Dehydration, Attention, Parietal lobe, Athlete, PVT, ENG, Motor cortex, GNG, Toy

More than just a technological marvel, Pison READY is poised to reshape the wearable tech scene.

Key Points: 
  • More than just a technological marvel, Pison READY is poised to reshape the wearable tech scene.
  • Its launch coincides with the start of the 2024 racing season, beginning with the Daytona 500, and Pison’s sponsorship of NASCAR Driver Anthony Alfredo.
  • “Anthony Alfredo was instrumental in the development of this key innovation at Pison.
  • Pison offers three membership options from three months for $59, a year for $119, and two years for $199.

Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program

Retrieved on: 
星期三, 十二月 6, 2023
Motor cortex, Food, ALS, Survival, Cerebrospinal fluid, IND, Plasma, Small RNA, Astrocyte, Spinal cord, Therapy, Animal, SOD1, Biomarker, Neurology, Neuron, Pharmaceutical industry

LEXINGTON, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that it has selected a lead development candidate for its superoxide dismutase 1 (SOD1)-mutated amyotrophic lateral sclerosis (ALS) gene therapy program.

Key Points: 
  • LEXINGTON, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that it has selected a lead development candidate for its superoxide dismutase 1 (SOD1)-mutated amyotrophic lateral sclerosis (ALS) gene therapy program.
  • The Company anticipates filing an investigational new drug (IND) application with the Food and Drug Administration for the candidate in mid-2025.
  • Voyager’s SOD1-ALS lead candidate combines a highly potent siRNA construct to decrease the expression of SOD1 with an IV-delivered, blood-brain barrier-penetrant TRACER™ capsid.
  • The candidate demonstrated robust knockdown of SOD1 across all levels of the spinal cord and motor cortex.

Aviv Clinics Highlights Case Report Showing Hyperbaric Oxygen Therapy Improves Post-Stroke Rehabilitation, Specifically Hand Motor Recovery

Retrieved on: 
星期一, 十月 2, 2023
Functional, FMA, Male, SMA, HBOT, Stroke, Frontiers, Weakness, Teaching, Oxygen, Quality of life, Tel Aviv University, Post-stroke depression, MVC, Hope, Brain, COVID, Magnetic resonance, National Association Medical Staff Services, MRI, Motor cortex, PMA, Patient, Traumatic brain injury, Shamir Medical Center, Resting state fMRI, Research, Health, Environment, Hyperbaric medicine, PTSD, Medical imaging, Pharmaceutical industry, Aviv, Neurology

ORLANDO, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Aviv Clinics , one of the world’s most advanced brain clinics, shares the results of a new case report showing a unique hyperbaric oxygen therapy (HBOT) protocol was effective for improving hand motor function in a chronic post-stroke patient.

Key Points: 
  • ORLANDO, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Aviv Clinics , one of the world’s most advanced brain clinics, shares the results of a new case report showing a unique hyperbaric oxygen therapy (HBOT) protocol was effective for improving hand motor function in a chronic post-stroke patient.
  • The case report, Functional MRI evaluation of hyperbaric oxygen therapy effect on hand motor recovery in a chronic post-stroke patient: a case report and physiological discussion , was conducted by a research team at the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University, and published in Frontiers in Neurology.
  • The case report evaluated the effect of a unique HBOT protocol to induce motor rehabilitation in a chronic post-stroke patient with severe upper-limb motor impairment.
  • The case report analyzed the patient’s functional MRI (fMRI) to evaluate the neural response mechanisms and functional reorganization of the patient’s brain following HBOT.

If anxiety is in my brain, why is my heart pounding? A psychiatrist explains the neuroscience and physiology of fear

Retrieved on: 
星期二, 九月 5, 2023
Butterfly, Extrapyramidal system, Learning, Neuron, Human, Travel, Sympathetic nervous system, Contract, Digestion, Anxiety, Oxygen, Spinal cord, Fear, Nutrient, Prefrontal cortex, Brain, Emotion, Stomach, Science, Hormone, Pain, Amygdala, Eminem, Motor cortex, Blood, Racism, Heart rate, Environment, Social environment, Hippocampus, Medical imaging, Nursing, Toy, Heart

These are all phrases many people use to describe fear and anxiety.

Key Points: 
  • These are all phrases many people use to describe fear and anxiety.
  • You have likely felt anxiety inside your chest or stomach, and your brain usually doesn’t hurt when you’re scared.
  • But science has traditionally seen the brain as the birthplace and processing site of fear and anxiety.

Fear and the brain

    • There are a few key areas of the brain that are heavily involved in processing fear.
    • For this reason, the amygdala evolved to bypass brain areas involved in logical thinking and can directly engage physical responses.
    • For example, seeing an angry lion in the zoo and in the Sahara both trigger a fear response in the amygdala.
    • Although the prefrontal cortex is usually seen as the part of the brain that regulates emotions, it can also teach you fear based on your social environment.

Fear and the rest of the body

    • But the body is where most of the action happens.
    • Several pathways prepare different body systems for intense physical action.
    • Sympathetic neurons are spread throughout the body and are especially dense in places like the heart, lungs and intestines.
    • These changes to your gastrointestinal system can be perceived as the discomfort linked to fear and anxiety.

It all goes back to the brain

    • Your already anxious and highly alert brain then processes these signals at both conscious and unconscious levels.
    • The insula is a part of the brain specifically involved in conscious awareness of your emotions, pain and bodily sensations.
    • Emotions take place in both your body and your brain, but you become aware of their existence with your brain.